PerkinElmer, Inc. has introduced the Western Lighting Ultra, a chemiluminescent substrate kit, at FASEB 2010 held in Anaheim, California.
Developed for determining post-translational modifications of proteins that are weakly expressed, the new kit offers stable signal, good sensitivity and a dynamic range for precise results in every area that applies to life science research.
Moreover, the usage of primary antibodies is reduced by 10 times by using the new kit.
The Western Lighting Ultra facilitates pharmacological research by overcoming issues faced in the cell signaling pathways investigation.
The General Manager and Vice President of PerkinElmer’s drug discovery and research reagent solutions, Bio-discovery division Martina Bielefeld-Sévigny commented that the new kit will benefit research work into potential novel drugs, offering in-depth information on the effectiveness of the novel drugs against critical diseases.
The increased signal stability and sensitivity of the new kit facilitates scientists to generate concrete results even when the proteins are expressed in terms of low or high levels, thereby saving resources and time by reducing the requirement for iterative experiments.